Literature DB >> 30500938

Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.

Muhammad Siyab Panhwar1, Emad Mansoor2, Sadeer G Al-Kindi3, Preetika Sinh2, Jeffry Katz2, Guilherme H Oliveira3, Gregory S Cooper2, Mahazarin Ginwalla3.   

Abstract

BACKGROUND &
OBJECTIVE: Chronic inflammation is linked to increased cardiovascular risk. Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract and elevated pro-inflammatory markers. The association between IBD and myocardial infarction (MI) is not well understood. We sought to elucidate this risk using a large database.
METHODS: We reviewed data from a large commercial database (Explorys, IBM Watson) that aggregates electronic medical records from 26 nationwide health care systems. Using systemized nomenclature of medicine-clinical terms, we identified adult patients (20 to 65 years) with a diagnosis of IBD-ulcerative colitis (UC) or Crohn's disease (CD)-who had active records between August 2013 and August 2018. We then examined the risk of MI in patients with or without IBD.
RESULTS: Out of 29,090,220 patients, 131,680 (0.45%) had UC, and 158,750 (0.55%) had CD. Prevalence of MI was higher in patients with UC and CD versus non-IBD patients (UC 6.7% vs CD 8.8% vs non-IBD 3.3%, odds ratio [OR] for UC 2.09 [2.04 -2.13], and CD 2.79 [2.74-2.85]. The odds of MI in IBD patients overall were highest in younger patients and decreased with age (age 30-34 years: OR 12.05 [11.16-13.01], age 65+ years: OR 2.08 [2.04-2.11]). After adjusting for age, race, sex, and traditional cardiovascular risk factor, IBD conferred greater odds of MI (adjusted odds ratio [aOR] 1.25 [1.24-1.27]).
CONCLUSION: In this large cohort, IBD is associated with significantly increased MI compared with non-IBD patients. The relative risk of MI was highest in younger patients and decreased with age. These findings emphasize the need for aggressive risk factor reduction in IBD.
© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular disease; inflammatory bowel disease; myocardial infarction

Mesh:

Year:  2019        PMID: 30500938     DOI: 10.1093/ibd/izy354

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  13 in total

1.  Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study.

Authors:  Mohammed Zaahid Sheriff; Emad Mansoor; Jay Luther; Ashwin N Ananthakrishnan; Mohannad Abou Saleh; Edith Ho; Farren B S Briggs; Maneesh Dave
Journal:  Inflamm Bowel Dis       Date:  2020-01-06       Impact factor: 5.325

2.  Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study.

Authors:  Ni Tien; Tien-Yuan Wu; Cheng-Li Lin; Chia-Jui Wu; Chung-Y Hsu; Yi-Jen Fang; Yun-Ping Lim
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 3.  Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Long Chen; Kai Hu; Cheng Cheng; Quanman Hu; Liang Zhang; Tongyan An; Yongjun Guo; Shuaiyin Chen; Guangcai Duan
Journal:  Int J Colorectal Dis       Date:  2022-10-22       Impact factor: 2.796

4.  Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart.

Authors:  Yanbo Tang; Kevin T Kline; Xiaoying S Zhong; Ying Xiao; Haifeng Lian; Jun Peng; Xiaowei Liu; Don W Powell; Guodu Tang; Qingjie Li
Journal:  PLoS One       Date:  2021-09-20       Impact factor: 3.752

Review 5.  Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.

Authors:  Yao Chen; Xiang Wang
Journal:  Brain Behav       Date:  2021-05-07       Impact factor: 2.708

6.  Arterial Stiffness in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis.

Authors:  Qiongqiong Lu; Rui Shi; Tangyou Mao; Zhibin Wang; Zhongmei Sun; Xiang Tan; Yi Wang; Junxiang Li
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.555

7.  Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases.

Authors:  Angelo Viscido; Annalisa Capannolo; Renata Petroni; Gianpiero Stefanelli; Giulia Zerboni; Massimo De Martinis; Stefano Necozione; Maria Penco; Giuseppe Frieri; Giovanni Latella; Silvio Romano
Journal:  Medicina (Kaunas)       Date:  2020-07-30       Impact factor: 2.430

8.  Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey.

Authors:  Khurram Nasir; Isaac Acquah; Amit K Dey; Tanushree Agrawal; Syed Zawahir Hassan; Kerri Glassner; Bincy Abraham; Eamonn M M Quigley; Ron Blankstein; Salim S Virani; Michael J Blaha; Javier Valero-Elizondo; Miguel Cainzos-Achirica; Nehal N Mehta
Journal:  Am J Prev Cardiol       Date:  2022-01-17

9.  Exosomal miR-29b of Gut Origin in Patients With Ulcerative Colitis Suppresses Heart Brain-Derived Neurotrophic Factor.

Authors:  Haifeng Lian; Xiaoying S Zhong; Ying Xiao; Zhe Sun; Yuanyuan Shen; Kaile Zhao; Xingbin Ma; Yanmin Li; Qiong Niu; Max Liu; Don W Powell; Chengxia Liu; Qingjie Li
Journal:  Front Mol Biosci       Date:  2022-02-22

Review 10.  Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Authors:  Gerhard Rogler; Abha Singh; Arthur Kavanaugh; David T Rubin
Journal:  Gastroenterology       Date:  2021-08-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.